- Home
- Publications
- Publication Search
- Publication Details
Title
Pathogenesis and management of essential thrombocythemia
Authors
Keywords
-
Journal
Hematology-American Society of Hematology Education Program
Volume 2009, Issue 1, Pages 621-628
Publisher
American Society of Hematology
Online
2009-12-12
DOI
10.1182/asheducation-2009.1.621
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Perspectives on thrombosis in essential thrombocythemia and polycythemia vera: is leukocytosis a causative factor?
- (2009) T. Barbui et al. BLOOD
- Clonal diversity in the myeloproliferative neoplasms: independent origins of genetically distinct clones
- (2009) Philip A. Beer et al. BRITISH JOURNAL OF HAEMATOLOGY
- Reticulin Accumulation in Essential Thrombocythemia: Prognostic Significance and Relationship to Therapy
- (2009) Peter J. Campbell et al. JOURNAL OF CLINICAL ONCOLOGY
- A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms
- (2009) Damla Olcaydu et al. NATURE GENETICS
- A germline JAK2 SNP is associated with predisposition to the development of JAK2V617F-positive myeloproliferative neoplasms
- (2009) Outi Kilpivaara et al. NATURE GENETICS
- JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms
- (2009) Amy V Jones et al. NATURE GENETICS
- Mutation inTET2in Myeloid Cancers
- (2009) François Delhommeau et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clonal heterogeneity in polycythemia vera patients with JAK2 exon12 and JAK2-V617F mutations
- (2008) S. Li et al. BLOOD
- Clonal analysis of deletions on chromosome 20q and JAK2-V617F in MPD suggests that del20q acts independently and is not one of the predisposing mutations for JAK2-V617F
- (2008) F. X. Schaub et al. BLOOD
- Characteristics and clinical correlates of MPL 515W>L/K mutation in essential thrombocythemia
- (2008) A. M. Vannucchi et al. BLOOD
- Pegylated interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia vera
- (2008) J.-J. Kiladjian et al. BLOOD
- MPL mutations in myeloproliferative disorders: analysis of the PT-1 cohort
- (2008) P. A. Beer et al. BLOOD
- Increased risks of polycythemia vera, essential thrombocythemia, and myelofibrosis among 24 577 first-degree relatives of 11 039 patients with myeloproliferative neoplasms in Sweden
- (2008) O. Landgren et al. BLOOD
- JAK2 stimulates homologous recombination and genetic instability: potential implication in the heterogeneity of myeloproliferative disorders
- (2008) I. Plo et al. BLOOD
- Natural killer cells recruited into lymph nodes inhibit alloreactive T-cell activation through perforin-mediated killing of donor allogeneic dendritic cells
- (2008) S. Laffont et al. BLOOD
- Inhibition of the Bcl-xLDeamidation Pathway in Myeloproliferative Disorders
- (2008) Rui Zhao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Downregulation of Signal Transducer and Activator of Transcription 5 (STAT5) in CD34+Cells Promotes Megakaryocytic Development, Whereas Activation of STAT5 Drives Erythropoiesis
- (2008) Sandra G. Olthof et al. STEM CELLS
- Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic mice
- (2007) R. Tiedt et al. BLOOD
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now